|
US2017161441A1
|
|
Methods and materials for treating pain and depression
|
|
US2015031064A1
|
|
Multiple biomarker panels to stratify disease severity and monitor treatment of depression
|
|
US2014273030A1
|
|
Human biomarker test for major depressive disorder
|
|
US2014257708A1
|
|
Diagnosing and monitoring depression disorders
|
|
US2014135224A1
|
|
Quantitative diagnostic methods using multiple parameters
|
|
CN103370624A
|
|
Biomarkers for monitoring treatment of neuropsychiatric diseases
|
|
CA2788315A1
|
|
Multiple biomarker panels to stratify disease severity and monitor treatment of depression
|
|
CN102460153A
|
|
Biomarkers for monitoring treatment of neuropsychiatric diseases
|
|
CN102483398A
|
|
Biomarkers for monitoring treatment of neuropsychiatric diseases
|
|
CN102301234B
|
|
Metabolic Syndrome And HPA Axis Biomarkers For Major Depressive Disorder
|
|
CN102257157A
|
|
Human biomarker hypermapping for depressive disorders
|
|
EP2272044A2
|
|
Inflammatory biomarkers for monitoring depression disorders
|
|
CN102037355A
|
|
Diagnosing and monitoring depression disorders based on multiple biomarker panels
|
